One potential concern when using HGF agonists as therapeutic agents is their impact on the cardiovascular system,25 such as the increased risk of endothelial deposition and arteriosclerosis due to the mobilization of lipids from the liver into the bloodstream. Here, HGF is linked to arteriosclerosis disorder.